Clemson bioengineer uses nanoparticles to target drugs
Date: 24.10.2009
Clemson **bioengineer** Frank Alexis is designing new ways to **target drugs** and reduce the chances for side effects.
Pharmaceutical commercials can cause the unsettling feeling that if the **disease** doesn't kill, the cure will, what with a drug's long list of side effects and warnings. Many **therapeutic drugs** administered by pill, cream, syringe, IV or liquid can be a hit or miss delivery system. Researchers report that only 1 of 100,000 molecules of an intravenous drug make it to the intended spot in the body.
"Clemson University":[ http://www.clemson.edu/media-relations/article.php?article_id=2311]
